A hSCARB2-transgenic mouse model for Coxsackievirus A16 pathogenesis

Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate...

Full description

Saved in:
Bibliographic Details
Published inVirology journal Vol. 18; no. 1; p. 84
Main Authors Chen, Yanli, Li, Heng, Yang, Jinxi, Zheng, Huiwen, Guo, Lei, Li, Weiyu, Yang, Zening, Song, Jie, Liu, Longding
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 21.04.2021
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate the neurological pathology observed in human HFMD more difficult. Because the human scavenger receptor class B, member 2 (hSCARB2) is a cellular receptor for CA16, we used transgenic mice bearing human SCARB2 and nasally infected them with CA16 to study the pathogenicity of the virus. Coxsackievirus A16 was administered by intranasal instillation to groups of hSCARB2 transgenic mice and clinical signs were observed. Sampled at different time-points to document and characterize the mode of viral dissemination, pathological change and immune response of CA16 infection. Weight loss and virus replication in lung and brain were observed in hSCARB2 mice infected with CA16, indicating that these animals could model the neural infection process. Viral antigens were observed in the alveolar epithelia and brainstem cells. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes into the alveolar interstitial in lung and diffuse punctate hemorrhages in the capillaries of the brainstem. In addition, we detected the expression levels of inflammatory cytokines and detected high levels of interleukin IL-1β, IL-6, IL-18, and IFN-γ in nasal mucosa, lungs and brain tissues. The hSCARB2-transgenic mice can be productively infected with CA16 via respiratory route and exhibited a clear tropism to lung and brain tissues, which can serve as a model to investigate the pathogenesis of CA16 associated respiratory and neurological disease.
AbstractList Abstract Background Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate the neurological pathology observed in human HFMD more difficult. Because the human scavenger receptor class B, member 2 (hSCARB2) is a cellular receptor for CA16, we used transgenic mice bearing human SCARB2 and nasally infected them with CA16 to study the pathogenicity of the virus. Methods Coxsackievirus A16 was administered by intranasal instillation to groups of hSCARB2 transgenic mice and clinical signs were observed. Sampled at different time-points to document and characterize the mode of viral dissemination, pathological change and immune response of CA16 infection. Results Weight loss and virus replication in lung and brain were observed in hSCARB2 mice infected with CA16, indicating that these animals could model the neural infection process. Viral antigens were observed in the alveolar epithelia and brainstem cells. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes into the alveolar interstitial in lung and diffuse punctate hemorrhages in the capillaries of the brainstem. In addition, we detected the expression levels of inflammatory cytokines and detected high levels of interleukin IL-1β, IL-6, IL-18, and IFN-γ in nasal mucosa, lungs and brain tissues. Conclusions The hSCARB2-transgenic mice can be productively infected with CA16 via respiratory route and exhibited a clear tropism to lung and brain tissues, which can serve as a model to investigate the pathogenesis of CA16 associated respiratory and neurological disease.
Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate the neurological pathology observed in human HFMD more difficult. Because the human scavenger receptor class B, member 2 (hSCARB2) is a cellular receptor for CA16, we used transgenic mice bearing human SCARB2 and nasally infected them with CA16 to study the pathogenicity of the virus. Coxsackievirus A16 was administered by intranasal instillation to groups of hSCARB2 transgenic mice and clinical signs were observed. Sampled at different time-points to document and characterize the mode of viral dissemination, pathological change and immune response of CA16 infection. Weight loss and virus replication in lung and brain were observed in hSCARB2 mice infected with CA16, indicating that these animals could model the neural infection process. Viral antigens were observed in the alveolar epithelia and brainstem cells. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes into the alveolar interstitial in lung and diffuse punctate hemorrhages in the capillaries of the brainstem. In addition, we detected the expression levels of inflammatory cytokines and detected high levels of interleukin IL-1[beta], IL-6, IL-18, and IFN-[gamma] in nasal mucosa, lungs and brain tissues. The hSCARB2-transgenic mice can be productively infected with CA16 via respiratory route and exhibited a clear tropism to lung and brain tissues, which can serve as a model to investigate the pathogenesis of CA16 associated respiratory and neurological disease.
BACKGROUNDCoxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate the neurological pathology observed in human HFMD more difficult. Because the human scavenger receptor class B, member 2 (hSCARB2) is a cellular receptor for CA16, we used transgenic mice bearing human SCARB2 and nasally infected them with CA16 to study the pathogenicity of the virus. METHODSCoxsackievirus A16 was administered by intranasal instillation to groups of hSCARB2 transgenic mice and clinical signs were observed. Sampled at different time-points to document and characterize the mode of viral dissemination, pathological change and immune response of CA16 infection. RESULTSWeight loss and virus replication in lung and brain were observed in hSCARB2 mice infected with CA16, indicating that these animals could model the neural infection process. Viral antigens were observed in the alveolar epithelia and brainstem cells. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes into the alveolar interstitial in lung and diffuse punctate hemorrhages in the capillaries of the brainstem. In addition, we detected the expression levels of inflammatory cytokines and detected high levels of interleukin IL-1β, IL-6, IL-18, and IFN-γ in nasal mucosa, lungs and brain tissues. CONCLUSIONSThe hSCARB2-transgenic mice can be productively infected with CA16 via respiratory route and exhibited a clear tropism to lung and brain tissues, which can serve as a model to investigate the pathogenesis of CA16 associated respiratory and neurological disease.
Background Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate the neurological pathology observed in human HFMD more difficult. Because the human scavenger receptor class B, member 2 (hSCARB2) is a cellular receptor for CA16, we used transgenic mice bearing human SCARB2 and nasally infected them with CA16 to study the pathogenicity of the virus. Methods Coxsackievirus A16 was administered by intranasal instillation to groups of hSCARB2 transgenic mice and clinical signs were observed. Sampled at different time-points to document and characterize the mode of viral dissemination, pathological change and immune response of CA16 infection. Results Weight loss and virus replication in lung and brain were observed in hSCARB2 mice infected with CA16, indicating that these animals could model the neural infection process. Viral antigens were observed in the alveolar epithelia and brainstem cells. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes into the alveolar interstitial in lung and diffuse punctate hemorrhages in the capillaries of the brainstem. In addition, we detected the expression levels of inflammatory cytokines and detected high levels of interleukin IL-1β, IL-6, IL-18, and IFN-γ in nasal mucosa, lungs and brain tissues. Conclusions The hSCARB2-transgenic mice can be productively infected with CA16 via respiratory route and exhibited a clear tropism to lung and brain tissues, which can serve as a model to investigate the pathogenesis of CA16 associated respiratory and neurological disease.
Abstract Background Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate the neurological pathology observed in human HFMD more difficult. Because the human scavenger receptor class B, member 2 (hSCARB2) is a cellular receptor for CA16, we used transgenic mice bearing human SCARB2 and nasally infected them with CA16 to study the pathogenicity of the virus. Methods Coxsackievirus A16 was administered by intranasal instillation to groups of hSCARB2 transgenic mice and clinical signs were observed. Sampled at different time-points to document and characterize the mode of viral dissemination, pathological change and immune response of CA16 infection. Results Weight loss and virus replication in lung and brain were observed in hSCARB2 mice infected with CA16, indicating that these animals could model the neural infection process. Viral antigens were observed in the alveolar epithelia and brainstem cells. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes into the alveolar interstitial in lung and diffuse punctate hemorrhages in the capillaries of the brainstem. In addition, we detected the expression levels of inflammatory cytokines and detected high levels of interleukin IL-1β, IL-6, IL-18, and IFN-γ in nasal mucosa, lungs and brain tissues. Conclusions The hSCARB2-transgenic mice can be productively infected with CA16 via respiratory route and exhibited a clear tropism to lung and brain tissues, which can serve as a model to investigate the pathogenesis of CA16 associated respiratory and neurological disease.
Background Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate the neurological pathology observed in human HFMD more difficult. Because the human scavenger receptor class B, member 2 (hSCARB2) is a cellular receptor for CA16, we used transgenic mice bearing human SCARB2 and nasally infected them with CA16 to study the pathogenicity of the virus. Methods Coxsackievirus A16 was administered by intranasal instillation to groups of hSCARB2 transgenic mice and clinical signs were observed. Sampled at different time-points to document and characterize the mode of viral dissemination, pathological change and immune response of CA16 infection. Results Weight loss and virus replication in lung and brain were observed in hSCARB2 mice infected with CA16, indicating that these animals could model the neural infection process. Viral antigens were observed in the alveolar epithelia and brainstem cells. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes into the alveolar interstitial in lung and diffuse punctate hemorrhages in the capillaries of the brainstem. In addition, we detected the expression levels of inflammatory cytokines and detected high levels of interleukin IL-1[beta], IL-6, IL-18, and IFN-[gamma] in nasal mucosa, lungs and brain tissues. Conclusions The hSCARB2-transgenic mice can be productively infected with CA16 via respiratory route and exhibited a clear tropism to lung and brain tissues, which can serve as a model to investigate the pathogenesis of CA16 associated respiratory and neurological disease. Keywords: Coxsackievirus A16 (CA16), Hand, Foot and mouth disease (HFMD), Human scavenger receptor class B, member 2 (hSCARB2), Respiratory and neurological pathology
Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate the neurological pathology observed in human HFMD more difficult. Because the human scavenger receptor class B, member 2 (hSCARB2) is a cellular receptor for CA16, we used transgenic mice bearing human SCARB2 and nasally infected them with CA16 to study the pathogenicity of the virus. Coxsackievirus A16 was administered by intranasal instillation to groups of hSCARB2 transgenic mice and clinical signs were observed. Sampled at different time-points to document and characterize the mode of viral dissemination, pathological change and immune response of CA16 infection. Weight loss and virus replication in lung and brain were observed in hSCARB2 mice infected with CA16, indicating that these animals could model the neural infection process. Viral antigens were observed in the alveolar epithelia and brainstem cells. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes into the alveolar interstitial in lung and diffuse punctate hemorrhages in the capillaries of the brainstem. In addition, we detected the expression levels of inflammatory cytokines and detected high levels of interleukin IL-1β, IL-6, IL-18, and IFN-γ in nasal mucosa, lungs and brain tissues. The hSCARB2-transgenic mice can be productively infected with CA16 via respiratory route and exhibited a clear tropism to lung and brain tissues, which can serve as a model to investigate the pathogenesis of CA16 associated respiratory and neurological disease.
ArticleNumber 84
Audience Academic
Author Chen, Yanli
Yang, Jinxi
Song, Jie
Liu, Longding
Li, Heng
Li, Weiyu
Yang, Zening
Guo, Lei
Zheng, Huiwen
Author_xml – sequence: 1
  givenname: Yanli
  surname: Chen
  fullname: Chen, Yanli
  organization: Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China
– sequence: 2
  givenname: Heng
  surname: Li
  fullname: Li, Heng
  organization: Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China
– sequence: 3
  givenname: Jinxi
  surname: Yang
  fullname: Yang, Jinxi
  organization: Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China
– sequence: 4
  givenname: Huiwen
  surname: Zheng
  fullname: Zheng, Huiwen
  organization: Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China
– sequence: 5
  givenname: Lei
  surname: Guo
  fullname: Guo, Lei
  organization: Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China
– sequence: 6
  givenname: Weiyu
  surname: Li
  fullname: Li, Weiyu
  organization: Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China
– sequence: 7
  givenname: Zening
  surname: Yang
  fullname: Yang, Zening
  organization: Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China
– sequence: 8
  givenname: Jie
  surname: Song
  fullname: Song, Jie
  email: songjie@imbcams.com.cn, songjie@imbcams.com.cn
  organization: Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China. songjie@imbcams.com.cn
– sequence: 9
  givenname: Longding
  orcidid: 0000-0001-8335-5613
  surname: Liu
  fullname: Liu, Longding
  email: longdingl@gmail.com, longdingl@gmail.com
  organization: Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China. longdingl@gmail.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33882964$$D View this record in MEDLINE/PubMed
BookMark eNptkltrFDEUxwep2It-AR9kwBd9mJqcXCZ5Edb1tlAQWgXfQiaX3ayzkzWZKfXbm-3W2hUJJOHkd_4n5_A_rY6GOLiqeo7ROcaCv8kYpGANAtwgzFjbsEfVCW4paSjA96MH9-PqNOc1QgR4K59Ux4QIAZLTk-r9rF5dzWeX76AZkx7y0g3B1Js4ZVd26_rax1TP403W5kdw1yFNuZ5hXm_1uIqFdjnkp9Vjr_vsnt2dZ9W3jx--zj83F18-Leazi8Yw2Y6NpUybjjFKQGIJ1grhHbfAXecBdwww9p0EijDymGgrWilZJ7xkHjuLBDmrFntdG_VabVPY6PRLRR3UbSCmpdJpDKZ3CgwAN4Z2UmvadZ3mWpbq3IDgxvK2aL3da22nbuOscUPpvz8QPXwZwkot47USiGNEeRF4dSeQ4s_J5VFtQjau7_XgyvgUMMwFJW27-_fLf9B1nNJQRlUoEJICFeQvtdSlgTD4WOqanaiacSYJbqWAQp3_hyrLuk0wxSA-lPhBwuuDhMKM7mZc6ilntbi6PGRhz5oUc07O388DI7XznNp7ThXPqVvPKVaSXjyc5H3KH5OR35jq0L0
CitedBy_id crossref_primary_10_1128_aac_00054_24
crossref_primary_10_1038_s41592_023_01896_x
crossref_primary_10_1016_j_virol_2024_109989
crossref_primary_10_3389_fmicb_2022_1101850
Cites_doi 10.1038/s41374-020-0456-x
10.1097/INF.0000000000001242
10.1371/journal.ppat.1000082
10.1080/14760584.2018.1510326
10.1155/2020/9273241
10.1038/emi.2017.49
10.1186/1743-422X-10-250
10.1128/JVI.00902-12
10.1016/j.vaccine.2016.04.029
10.1128/JVI.02070-12
10.3389/fmicb.2020.00261
10.1016/j.antiviral.2014.02.015
10.1242/jcs.00075
10.1097/MD.0000000000011610
10.1016/S0962-8924(03)00005-9
10.1186/s12879-015-0965-1
10.1128/JVI.02358-10
10.1542/pir.19.6.183
10.1128/JVI.00692-14
10.1038/s41598-019-47455-3
10.1128/JVI.00020-12
10.1097/MD.0000000000018464
10.1128/JVI.06103-11
10.1002/path.4438
10.4049/jimmunol.1700352
10.4161/hv.27087
10.1111/nyas.13126
10.1093/hmg/ddg062
10.1073/pnas.1217563110
10.1038/srep34299
10.1016/j.coviro.2013.01.001
10.3389/fmicb.2020.00540
10.1371/journal.pone.0057591
10.1016/j.ajic.2015.04.202
10.3390/v7112916
10.1038/nm.1992
10.1016/j.vaccine.2019.07.046
10.1016/j.virol.2016.10.031
10.1186/s12929-020-0615-9
10.1016/j.virusres.2018.07.008
10.1038/srep31151
10.7883/yoken.JJID.2018.035
10.1097/INF.0000000000001093
10.1016/j.diagmicrobio.2013.02.011
ContentType Journal Article
Copyright COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021
Copyright_xml – notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
ISR
3V.
7U9
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12985-021-01557-5
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Gale In Context: Science
ProQuest Central (Corporate)
Virology and AIDS Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest - Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
Virology and AIDS Abstracts
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
AIDS and Cancer Research Abstracts
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
Publicly Available Content Database
CrossRef


MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1743-422X
EndPage 84
ExternalDocumentID oai_doaj_org_article_2c226cc4b9aa4bbba6a95ac6c286cd67
A659317982
10_1186_s12985_021_01557_5
33882964
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
United States--US
GeographicLocations_xml – name: China
– name: United States--US
GrantInformation_xml – fundername: ;
– fundername: ;
  grantid: 2018ZF006
– fundername: ;
  grantid: 2016-I2M-1-014
– fundername: ;
  grantid: 3332019004
– fundername: ;
  grantid: H-2017034
– fundername: ;
  grantid: 31700153
– fundername: ;
  grantid: 1540001
GroupedDBID ---
-A0
0R~
123
29Q
2WC
3V.
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAHBH
AAJSJ
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
ECM
EIF
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IFM
IGS
IHR
INH
INR
ISR
ITC
KQ8
LGEZI
LOTEE
M1P
M48
M~E
NADUK
NPM
NXXTH
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
UKHRP
WOQ
WOW
XSB
AAYXX
AFPKN
CITATION
AFGXO
ABVAZ
AFNRJ
7U9
7XB
8FK
AZQEC
DWQXO
H94
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c597t-d45acb554329192dd88fe6d26ebf21b5211fb924010f13ad87995b8f95f1ed083
IEDL.DBID RPM
ISSN 1743-422X
IngestDate Tue Oct 22 15:08:34 EDT 2024
Tue Sep 17 21:20:30 EDT 2024
Fri Oct 25 11:30:54 EDT 2024
Thu Oct 10 20:30:25 EDT 2024
Thu Feb 22 23:56:43 EST 2024
Tue Nov 12 23:14:38 EST 2024
Thu Aug 01 19:27:26 EDT 2024
Thu Sep 12 16:51:53 EDT 2024
Wed Oct 16 00:41:43 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Respiratory and neurological pathology
Foot and mouth disease (HFMD)
Coxsackievirus A16 (CA16)
Human scavenger receptor class B
Hand
member 2 (hSCARB2)
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c597t-d45acb554329192dd88fe6d26ebf21b5211fb924010f13ad87995b8f95f1ed083
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-8335-5613
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061046/
PMID 33882964
PQID 2528942483
PQPubID 55248
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_2c226cc4b9aa4bbba6a95ac6c286cd67
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8061046
proquest_miscellaneous_2516843778
proquest_journals_2528942483
gale_infotracmisc_A659317982
gale_infotracacademiconefile_A659317982
gale_incontextgauss_ISR_A659317982
crossref_primary_10_1186_s12985_021_01557_5
pubmed_primary_33882964
PublicationCentury 2000
PublicationDate 2021-04-21
PublicationDateYYYYMMDD 2021-04-21
PublicationDate_xml – month: 04
  year: 2021
  text: 2021-04-21
  day: 21
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Virology journal
PublicationTitleAlternate Virol J
PublicationYear 2021
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References AT Liou (1557_CR31) 2016; 6
P Yao (1557_CR14) 2019; 37
N Ye (1557_CR40) 2015; 15
D Safronetz (1557_CR43) 2013; 3
J Wang (1557_CR19) 2017; 500
B-S Chen (1557_CR6) 2020; 11
A Majer (1557_CR7) 2020; 11
YT Hooi (1557_CR17) 2020; 100
1557_CR5
Y Sun (1557_CR16) 2016; 6
1557_CR1
CC Liao (1557_CR47) 2014; 88
Y-W Lin (1557_CR29) 2013; 8
K Kobayashi (1557_CR20) 2020; 27
S Yamayoshi (1557_CR22) 2009; 15
Q Zhu (1557_CR33) 2017; 198
EL Eskelinen (1557_CR27) 2003; 13
EA Caine (1557_CR13) 2015; 7
T Zaoutis (1557_CR11) 1998; 19
W Zhang (1557_CR38) 2020; 2020
X Li (1557_CR23) 2013; 10
K Fujii (1557_CR30) 2013; 110
DA Food (1557_CR41) 2002; 67
L Sun (1557_CR10) 2016; 44
C-Y Fang (1557_CR2) 2018; 17
C Li (1557_CR44) 2018; 255
D Zhu (1557_CR46) 2013; 76
A Muehlenbachs (1557_CR8) 2015; 235
S Yamayoshi (1557_CR24) 2013; 87
Q Liu (1557_CR12) 2014; 105
L Jian-Ping (1557_CR18) 2014; 35
WX Khong (1557_CR45) 2012; 86
SK Kuss (1557_CR48) 2008; 4
T Kuronita (1557_CR26) 2002; 115
S Zhou (1557_CR32) 2016; 34
H de Graaf (1557_CR3) 2016; 35
WK Phyu (1557_CR9) 2017; 6
Q Mao (1557_CR15) 2012; 86
S Yamayoshi (1557_CR21) 2012; 86
C Chang (1557_CR34) 2019; 9
S Yamayoshi (1557_CR25) 2011; 85
X Rao (1557_CR35) 2013; 3
D-q Yin (1557_CR37) 2018; 71
GD Park (1557_CR42) 2016; 1374
S Owatanapanich (1557_CR4) 2016; 99
AC Gamp (1557_CR28) 2003; 12
Q Mao (1557_CR36) 2014; 10
Y Xu (1557_CR39) 2019; 98
References_xml – volume: 99
  start-page: 322
  year: 2016
  ident: 1557_CR4
  publication-title: J Med Assoc Thai
  contributor:
    fullname: S Owatanapanich
– volume: 100
  start-page: 1262
  year: 2020
  ident: 1557_CR17
  publication-title: Lab Invest
  doi: 10.1038/s41374-020-0456-x
  contributor:
    fullname: YT Hooi
– ident: 1557_CR1
  doi: 10.1097/INF.0000000000001242
– volume: 4
  start-page: e1000082
  year: 2008
  ident: 1557_CR48
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1000082
  contributor:
    fullname: SK Kuss
– volume: 17
  start-page: 819
  year: 2018
  ident: 1557_CR2
  publication-title: Expert Rev Vaccines
  doi: 10.1080/14760584.2018.1510326
  contributor:
    fullname: C-Y Fang
– volume: 2020
  start-page: 9273241
  year: 2020
  ident: 1557_CR38
  publication-title: Mediators Inflamm
  doi: 10.1155/2020/9273241
  contributor:
    fullname: W Zhang
– volume: 6
  start-page: 1
  year: 2017
  ident: 1557_CR9
  publication-title: Emerg Microbes Infect
  doi: 10.1038/emi.2017.49
  contributor:
    fullname: WK Phyu
– volume: 10
  start-page: 250
  year: 2013
  ident: 1557_CR23
  publication-title: Virol J
  doi: 10.1186/1743-422X-10-250
  contributor:
    fullname: X Li
– volume: 86
  start-page: 11967
  year: 2012
  ident: 1557_CR15
  publication-title: J Virol
  doi: 10.1128/JVI.00902-12
  contributor:
    fullname: Q Mao
– volume: 34
  start-page: 2729
  year: 2016
  ident: 1557_CR32
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2016.04.029
  contributor:
    fullname: S Zhou
– volume: 87
  start-page: 3335
  year: 2013
  ident: 1557_CR24
  publication-title: J Virol
  doi: 10.1128/JVI.02070-12
  contributor:
    fullname: S Yamayoshi
– volume: 11
  start-page: 261
  year: 2020
  ident: 1557_CR6
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2020.00261
  contributor:
    fullname: B-S Chen
– volume: 105
  start-page: 26
  year: 2014
  ident: 1557_CR12
  publication-title: Antiviral Res
  doi: 10.1016/j.antiviral.2014.02.015
  contributor:
    fullname: Q Liu
– volume: 115
  start-page: 4117
  year: 2002
  ident: 1557_CR26
  publication-title: J Cell Sci
  doi: 10.1242/jcs.00075
  contributor:
    fullname: T Kuronita
– volume: 67
  start-page: 37988
  year: 2002
  ident: 1557_CR41
  publication-title: Fed Reg
  contributor:
    fullname: DA Food
– ident: 1557_CR5
  doi: 10.1097/MD.0000000000011610
– volume: 13
  start-page: 137
  year: 2003
  ident: 1557_CR27
  publication-title: Trends Cell Biol
  doi: 10.1016/S0962-8924(03)00005-9
  contributor:
    fullname: EL Eskelinen
– volume: 15
  start-page: 225
  year: 2015
  ident: 1557_CR40
  publication-title: BMC Infect Dis
  doi: 10.1186/s12879-015-0965-1
  contributor:
    fullname: N Ye
– volume: 85
  start-page: 4937
  year: 2011
  ident: 1557_CR25
  publication-title: J Virol
  doi: 10.1128/JVI.02358-10
  contributor:
    fullname: S Yamayoshi
– volume: 19
  start-page: 183
  year: 1998
  ident: 1557_CR11
  publication-title: Pediatrics Rev
  doi: 10.1542/pir.19.6.183
  contributor:
    fullname: T Zaoutis
– volume: 88
  start-page: 12485
  year: 2014
  ident: 1557_CR47
  publication-title: J Virol
  doi: 10.1128/JVI.00692-14
  contributor:
    fullname: CC Liao
– volume: 9
  start-page: 11108
  year: 2019
  ident: 1557_CR34
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-47455-3
  contributor:
    fullname: C Chang
– volume: 86
  start-page: 5686
  year: 2012
  ident: 1557_CR21
  publication-title: J Virol
  doi: 10.1128/JVI.00020-12
  contributor:
    fullname: S Yamayoshi
– volume: 98
  start-page: e18464
  year: 2019
  ident: 1557_CR39
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000018464
  contributor:
    fullname: Y Xu
– volume: 35
  start-page: 485
  year: 2014
  ident: 1557_CR18
  publication-title: Zool Res
  contributor:
    fullname: L Jian-Ping
– volume: 86
  start-page: 2121
  year: 2012
  ident: 1557_CR45
  publication-title: J Virol
  doi: 10.1128/JVI.06103-11
  contributor:
    fullname: WX Khong
– volume: 235
  start-page: 217
  year: 2015
  ident: 1557_CR8
  publication-title: J Pathol
  doi: 10.1002/path.4438
  contributor:
    fullname: A Muehlenbachs
– volume: 198
  start-page: 4210
  year: 2017
  ident: 1557_CR33
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1700352
  contributor:
    fullname: Q Zhu
– volume: 10
  start-page: 360
  year: 2014
  ident: 1557_CR36
  publication-title: Hum Vaccin Immunother
  doi: 10.4161/hv.27087
  contributor:
    fullname: Q Mao
– volume: 1374
  start-page: 10
  year: 2016
  ident: 1557_CR42
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/nyas.13126
  contributor:
    fullname: GD Park
– volume: 12
  start-page: 631
  year: 2003
  ident: 1557_CR28
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddg062
  contributor:
    fullname: AC Gamp
– volume: 110
  start-page: 14753
  year: 2013
  ident: 1557_CR30
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1217563110
  contributor:
    fullname: K Fujii
– volume: 6
  start-page: 34299
  year: 2016
  ident: 1557_CR16
  publication-title: Sci Rep
  doi: 10.1038/srep34299
  contributor:
    fullname: Y Sun
– volume: 3
  start-page: 205
  year: 2013
  ident: 1557_CR43
  publication-title: Curr Opin Virol
  doi: 10.1016/j.coviro.2013.01.001
  contributor:
    fullname: D Safronetz
– volume: 11
  start-page: 540
  year: 2020
  ident: 1557_CR7
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2020.00540
  contributor:
    fullname: A Majer
– volume: 8
  start-page: e57591
  year: 2013
  ident: 1557_CR29
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0057591
  contributor:
    fullname: Y-W Lin
– volume: 44
  start-page: e13
  year: 2016
  ident: 1557_CR10
  publication-title: Am J Infect Control
  doi: 10.1016/j.ajic.2015.04.202
  contributor:
    fullname: L Sun
– volume: 7
  start-page: 5919
  year: 2015
  ident: 1557_CR13
  publication-title: Viruses
  doi: 10.3390/v7112916
  contributor:
    fullname: EA Caine
– volume: 3
  start-page: 71
  year: 2013
  ident: 1557_CR35
  publication-title: Biostat Bioinforma Biomath
  contributor:
    fullname: X Rao
– volume: 15
  start-page: 798
  year: 2009
  ident: 1557_CR22
  publication-title: Nat Med
  doi: 10.1038/nm.1992
  contributor:
    fullname: S Yamayoshi
– volume: 37
  start-page: 5341
  year: 2019
  ident: 1557_CR14
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2019.07.046
  contributor:
    fullname: P Yao
– volume: 500
  start-page: 198
  year: 2017
  ident: 1557_CR19
  publication-title: Virology
  doi: 10.1016/j.virol.2016.10.031
  contributor:
    fullname: J Wang
– volume: 27
  start-page: 23
  year: 2020
  ident: 1557_CR20
  publication-title: J Biomed Sci
  doi: 10.1186/s12929-020-0615-9
  contributor:
    fullname: K Kobayashi
– volume: 255
  start-page: 117
  year: 2018
  ident: 1557_CR44
  publication-title: Virus Res
  doi: 10.1016/j.virusres.2018.07.008
  contributor:
    fullname: C Li
– volume: 6
  start-page: 31151
  year: 2016
  ident: 1557_CR31
  publication-title: Sci Rep
  doi: 10.1038/srep31151
  contributor:
    fullname: AT Liou
– volume: 71
  start-page: 470
  year: 2018
  ident: 1557_CR37
  publication-title: Jpn J Infect Dis
  doi: 10.7883/yoken.JJID.2018.035
  contributor:
    fullname: D-q Yin
– volume: 35
  start-page: 723
  year: 2016
  ident: 1557_CR3
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/INF.0000000000001093
  contributor:
    fullname: H de Graaf
– volume: 76
  start-page: 162
  year: 2013
  ident: 1557_CR46
  publication-title: Diagn Microbiol Infect Dis
  doi: 10.1016/j.diagmicrobio.2013.02.011
  contributor:
    fullname: D Zhu
SSID ssj0032679
Score 2.3575485
Snippet Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD),...
Abstract Background Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and...
Background Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth...
BACKGROUNDCoxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease...
Abstract Background Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 84
SubjectTerms Alveoli
Analysis
Animal models
Animals
Antigens
Antigens, Viral
Brain stem
Capillaries
Coxsackievirus
Coxsackievirus A16 (CA16)
Coxsackievirus Infections
Coxsackieviruses
Disease Models, Animal
Enterovirus
Foot and mouth disease (HFMD)
Hand
Hand-foot-and-mouth disease
Health aspects
Host range
Host-virus relationships
Human scavenger receptor class B
IL-1β
Immune response
Infections
Inflammation
Interleukin 18
Interleukin 6
Laboratory animals
Lymphocytes
Medical research
member 2 (hSCARB2)
Mice
Mice, Transgenic
Mucosa
Neurological diseases
Pathogenesis
Pathogenicity
Pathology
Respiratory and neurological pathology
Rodents
Scavenger receptors
Transgenic animals
Transgenic mice
Tropism
Virulence (Microbiology)
Virus Replication
Virus research
Viruses
γ-Interferon
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9RAFB-koHgRW79Sq0QRPMjQzXxlckxXSxXqobXQ2zAfmXYRstLsgv73fW8mu2zw4MXbknkJm997M-_9yPsg5AOLGs79IKiDaJ4iQ6DAVRS1-JMrHmKqrTr_rs6uxLdreb0z6gtzwnJ74AzcMfMQIHgvXGOtcM5ZZRtpvfJMKx9UriOfNRsylc9giEnqZlMio9XxAF5NYyUyUmcpayonbih16__7TN5xStOEyR0PdPqUPBlDx7LNf3mfPOj6A_IwD5P8c0AenY-fyZ-Rz215ezlvL04YXaEvAiNZ-BJJflem0TclhKrlfPl7sP7nAvN810PZVqrE-cTLGzz-FsNzcnX65cf8jI7jEqgHVrCiQQAuDsIDzhqI20LQOnYqMNW5yCoHfrqKDugWMLBYcRs09oJzOjYyVl2AUOwF2euXffeKlAAsgAzcDx4ivJZ6hsOFoorwOOe5LsinDXrmV-6KYRKb0MpkrA1gbRLWRhbkBAHeSmJH63QB9GxGPZt_6bkg71E9BntW9JgUc2PXw2C-Xl6YVsmGY-M1VpCPo1BcAr7ejjUG8FbY5moieTSRhE3lp8sbKzDjph4Mk2DPggnNC_Juu4x3YqJa34EWQaZSWvC6BoxeZqPZvjfnQGcaJQpST8xpAsx0pV_cppbfGsKumVCH_wPJ1-QxSztBUFYdkb3V3bp7A5HVyr1Nm-geDzEeIg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96ovgien5VT6ki-CDhtvlq-iS91eMUzoc7D_YtJGmztwjted0F_e-dSbPrFcG30kxDOplkfr92MkPIOxY07PuNoA7QPEWGQIGrKGrxkivehHi26vSbOrkQXxdykT64DSmscrsnxo266T1-Iz9kEjoTTGj-8eonxapR-Hc1ldC4Te4UbKYwpKtc7AgXIJOYaw9BNxWMLbaHZrQ6HMDPaTybjGRaypLKiWOK-fv_3aVvuKlpCOUNn3T8kDxIYDKvx9l_RG613T65O5aX_L1P7p2mH-ePyac6vzyf12dHjK7RO4HZrHyOtL_NYzGcHMBrPu9_Ddb_WGHk72bI60LlWLG4X-KGuBqekIvjz9_nJzQVUKAeeMKaNkJa7wAwcFYBkmsarUOrGqZaF1jhwHMXwQEBA04WCm4bjdnhnA6VDEXbADh7Sva6vmufk9w3qpIW2CB0IryWeoblhoIK0J3zXGfkw1Z75mrMk2Eiv9DKjLo2oGsTdW1kRo5QwTtJzHEdb_TXS5OWjGEeoKH3wlXWCuecVRaG4JVnWsFwyoy8xekxmMWiwzCZpd0Mg_lyfmZqJSuOqdhYRt4nodCDfr1Npw7grTDx1UTyYCIJy8xPm7dWYNIyH8xfo8zIm10zPomha10LswgyhdKClyXo6NloNLv35hwITqVERsqJOU0UM23pVpcxCbgGIDYT6sX_h_WS3GfRxgVlxQHZW19v2leAotbudVwqfwCAzRYh
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELfGEIgXBOMrMFBASDwgs8VfcR4QygrTQBoPG5X6ZtlO3FWgBJpW2v577tykWsTEW1VfLOdy5_v9kvMdIW9Z0LDvV4I6QPMUGQIFrqKoxZ9c8SrEs1Wn39XJVHybydkOGdod9QrsbqR22E9quvz14fLP1Sdw-I_R4bU66CBmaTxnjMRYypzKW-Q2E8DUMZVPbL8qAFKJtfcQhFPB2Gw4RHPjHKNAFev5_7trXwtb45TKazHq-AG534PLtNxYw0OyUzd75M6m3eTVHrl72n9If0Q-l-nF-aQ8O2J0hdEKzGjhU3wNUKexOU4KYDadtJed9T8XmAm87tIyUyl2MG7nuEEuusdkevzlx-SE9g0VqAfesKKVkNY7ABCcFYDsqkrrUKuKqdoFljmI5FlwQMiAo4WM20pjtTinQyFDVlcA1p6Q3aZt6mck9ZUqpAV2CJMIr6U-xPZDQQWYznmuE_J-0J75vambYSLf0MpsdG1A1ybq2siEHKGCt5JY8zr-0S7npnchwzxARe-FK6wVzjmrLCzBK8-0guXkCXmDj8dgVYsG02bmdt115uv5mSmVLDiWZmMJedcLhRb0621_CgHuCgthjST3R5Lgdn48PFiBGazWMAkWL5jQPCGvt8N4JaayNTU8RZDJlBY8z0FHTzdGs71vzoHwFEokJB-Z00gx45FmcRGLgmsAZodCPf__sl6QeyzauKAs2ye7q-W6fgmoauVeRVf5C05bGU0
  priority: 102
  providerName: Scholars Portal
Title A hSCARB2-transgenic mouse model for Coxsackievirus A16 pathogenesis
URI https://www.ncbi.nlm.nih.gov/pubmed/33882964
https://www.proquest.com/docview/2528942483
https://search.proquest.com/docview/2516843778
https://pubmed.ncbi.nlm.nih.gov/PMC8061046
https://doaj.org/article/2c226cc4b9aa4bbba6a95ac6c286cd67
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe2IRAvCMZXYFQBIfGAshLHdpzHtGwaSJ2mjkl9s2wn7iJYMi2tBP89d05SLeKNl6iKL5FzvvPdr74PQj5SJ2HfL1hkwJuPECFEgFVEpPFnIpLC-dyqxbk4u2LfV3y1R_iQC-OD9q2pjutfN8d1de1jK29v7HSIE5teLOYSjBAeTe6TfRDQAaJ32y-4I2k2ZMdIMW3BoElMQkbUzHkaYa8awGUSzxtHxsjX7P93Z75nmsZhk_fs0OlT8qR3IMO8m-gzslfWh-Rh11LyzyF5tOgPy5-Tr3l4fTnPlzMabdAigahUNkSoX4a-AU4IDms4b3632v6sMNp324Z5LELsUtyscROs2hfk6vTkx_ws6psmRBawwSYqGNfWgJOQ0Ay8t6KQ0pWioKI0jsYGrHXsDIAuwGEuTnQhsSKckS7jLi4LcMhekoO6qcvXJLSFyLgGBAgvYVZy-QVbDDnh4HXGJjIgnwfuqduuNobymEIK1bFdAduVZ7viAZkhg3eUWNfa32ju1qpfXUUtuIPWMpNpzYwxWmiYghWWSgHTSQPyAZdHYeWKGkNj1nrbturb5VLlgmcJll-jAfnUE7kG-Gt1n2kAX4XFrkaURyNKUC07Hh6kQPWq3SrKQaoZZTIJyPvdMD6J4Wp1CasINLGQLElT4NGrTmh23z3IXkDSkTiNGDMeAT3whb97uX_z30--JY-p1wQW0fiIHGzutuU7cKo2ZgKqtEon5MHs5PxiOfF_TcB1weTEq9dfKPghXg
link.rule.ids 230,315,730,783,787,867,888,2109,12068,21400,24330,27936,27937,31731,31732,33756,33757,43322,43817,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagiMcFQXk0UCAgJA7IauPYjnNC24VqC90e-pD2ZtlOvF0hJW2zK8G_Z8bxLo2QuEXxxHLG45nvS-wZQj4yr8DvV5xaQPMUGQIFriKpwctc5pUPZ6umJ3Jywb_PxCx-cOvitsq1TwyOumodfiPfYwI644yr_MvVNcWqUfh3NZbQuEvuYR4urGBQzDaEC5BJyLWHoJtyxmbrQzNK7nUQ5xSeTUYyLURBxSAwhfz9_3rpW2FquIXyVkw6fEIeRzCZjvrZf0ru1M02ud-Xl_y9TR5M44_zZ-TrKL08G49ODxhdYnQCs1m4FGl_nYZiOCmA13Tc_uqM-7nAnb-rLh1lMsWKxe0cHeKie04uDr-djyc0FlCgDnjCklZcGGcBMOSsBCRXVUr5WlZM1tazzELkzrwFAgaczGe5qRRmh7PKl8JndQXg7AXZatqm3iGpq2QpDLBB6IQ7JdQ-lhvy0kN31uUqIZ_X2tNXfZ4MHfiFkrrXtQZd66BrLRJygAreSGKO63CjvZnruGQ0cwANneO2NIZba400MAQnHVMShlMk5ANOj8YsFg1uk5mbVdfpo7NTPZKizDEVG0vIpyjkW9CvM_HUAbwVJr4aSO4OJGGZuWHz2gp0XOad_muUCXm_acYncetaU8MsgkwmFc-LAnT0sjeazXvnORCcUvKEFANzGihm2NIsLkMScAVAbJ_LV_8f1jvycHI-PdbHRyc_XpNHLNg7pyzbJVvLm1X9BhDV0r4Ny-YPoskZCA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Rb9MwELZgiIkXBANGYEBASDwgr4vjOM5j11FtQKdpY9LeLNuJu2hbUi2tBP-eOyepGvHGW1VfIud85_s--XxHyGfmJOz7OacG0DxFhkCBqwiq8Wcs4tz5u1WzU3F8yb9fJVcbrb580r415X51e7dfldc-t3JxZ0d9ntjobDaREITwaHKRu9FD8gh89kD0RL3dhAGUpFl_R0aKUQNhTeJVZOTOSZJS7FgD7EziqeMgJPnK_f_uzxsBapg8uRGNps_I0w5GhuN2us_Jg6LaIY_bxpJ_dsj2rDsyf0GOxuH1xWR8fsjoEuMSGExpQyT8Rejb4IQAW8NJ_bvR9qbEnN9VE44jEWKv4nqOW2HZvCSX02-_Jse0a51ALTCEJc15oq0BqBCzDDBcnkvpCpEzURjHIgMxO3IGqBewMRfFOpdYF85IlyUuKnKAZa_IVlVXxWsS2lxkiQYeCC_hVibyABsNOeHgdcbGMiBfe-2pRVshQ3lmIYVq1a5A7cqrXSUBOUQFryWxurX_o76fq26NFbMACq3lJtOaG2O00DAFKyyTAqaTBuQTLo_C-hUVJsjM9app1MnFuRqLJIuxCBsLyJdOyNWgX6u7-wbwVVjyaiC5N5AEB7PD4d4KVOfgjWIJ2DZnXMYB-bgexicxaa0qYBVBJhKSx2kKOtptjWb93b3tBSQdmNNAMcMR8AZf_ruz_jf__eQHsn12NFU_T05_vCVPmHcKTlm0R7aW96viHaCspXnv_ekvS-Ihdw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+hSCARB2-transgenic+mouse+model+for+Coxsackievirus+A16+pathogenesis&rft.jtitle=Virology+journal&rft.au=Chen%2C+Yanli&rft.au=Li%2C+Heng&rft.au=Yang%2C+Jinxi&rft.au=Zheng%2C+Huiwen&rft.date=2021-04-21&rft.pub=BioMed+Central&rft.issn=1743-422X&rft.eissn=1743-422X&rft.volume=18&rft.spage=1&rft_id=info:doi/10.1186%2Fs12985-021-01557-5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1743-422X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1743-422X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1743-422X&client=summon